GLP1R and obesity due to melanocortin 4 receptor deficiency: Since GLP-1 signaling exerts clear beneficial effects in obesity, T2D and aging, it must potently ameliorate a common pathological thread across these conditions: chronic low-level inflammation and endothelial dysfunction.